Modified CoMFA methods for the analysis of antineoplastic effects of lignan analogues

Journal of Molecular Structure: THEOCHEM

Volumn 504, Issue 1-3, 2000, Pages 287-294

  Broughton, H B ^a   Gordaliza, M ^b   Castro, M A ^b   Miguel Del Corral, J M ^b   San Feliciano, A ^b  

^a Merck Sharp & Dohme Limited   (United Kingdom)

^b Camp miguel U   (Spain)

Author keywords

Antineoplastic; Average; CoMFA; Lignan; Natural product

Indexed keywords

ANTINEOPLASTIC AGENT; LIGNAN; NATURAL PRODUCT; PODOPHYLLOTOXIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONFORMATION; DRUG ACTIVITY; DRUG SCREENING; HUMAN CELL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 0034640721     PISSN: 01661280     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-1280(00)00369-9     Document Type: Article

References (26)

1. Ayres D.C., Loike J.D. Lignans. Chemical, Bological and Clinical Properties. 1990;Cambridge University Press, Cambridge, UK. (chaps 3 and 4).
2. Ward R.S. Nat. Prod. Rep. 16:1999;75.
3. Damayanthi Y., Lown J.W. Curr. Med. Chem. 5:1998;205.
4. Jardin I. Cassady J.M., Douros J.D. Podophyllotoxins in Anticancer Agents Based on Natural Product Models. 1980;Academic Press, New York.
5. Belani C.P., Doyle L.A., Aisner J. Etoposide: Current status and future perspectives in the management of malignant neoplasms. Cancer Chemother. Pharmacol. 34:1994;S118.
6. Muggia F.M. Cancer Chemother. Pharmacol. 34:1994;S127.
7. Witterland A.H., Koks C.H., Beijnen J.H. Pharm. World Sci. 18:1996;163.
8. Loike J.D., Brewer C.F., Sternlicht H., Gensler W.J., Horwitz S.B. Cancer Res. 38:1978;2688.
9. Loike J.D., Horwitz S.B. Biochemistry. 15:1976;5435.
10. Long B.H., Musial S.T., Brattain M.B. Biochemistry. 23:1984;1183.
11. Ross R., Rowe T., Glisson B., Yalowich J., Liu F. Cancer Res. 44:1984;2857.
12. Cho S.J., Kashiwada Y., Bastow K.F., Cheng Y.C., Lee K.H. J. Med. Chem. 39:1996;1396.
13. San Feliciano A., Gordaliza M., Miguel del Corral J.M., Castro M.A., García-Grávalos M.D., Ruiz-Lázaro P. Planta Med. 59:1993;246.
14. Gordaliza M., Castro M.A., García-Grávalos M.D., Ruiz-Lázaro P., Miguel del Corral J.M., San Feliciano A. Arch. Pharmacol. (Weinheim). 327:1994;175.
15. Gordaliza M., Miguel del Corral J.M., Castro M.A., López-Vázquez M.L., San Feliciano A., García-Grávalos M.D., Carpy A. Bioorg. Med. Chem. 3:1995;1203.
16. Gordaliza M., Miguel del Corral J.M., Castro M.A., López-Vázquez M.L., García P.D., San Feliciano A., García-Grávalos M.D. Bioorg. Med. Chem. Lett. 5:1995;2465.
17. Miguel del Corral J.M., Gordaliza M., Castro M.A., López-Vázquez M.L., García-Grávalos M.D., Broughton H.B., San Feliciano A. Tetrahedron. 53:1997;6555.
18. Cho S.J., Tropsha A., Suffness M., Cheng Y.C., Lee K.H. J. Med. Chem. 39:1996;383.
19. Zhu X.K., Guan J., Tachibana Y., Bastow K.F., Cho S.J., Cheng H.H., Cheng Y.C., Gurwith M., Lee K.H. J. Med. Chem. 42:1999;2441.
20. Perspectives in Drug Discovery vols 12/13/14, Series Editors P.S. Anderson, G.L Kenyou, G.R. Marshall "3D QSAR in Drug Design: Recent Advances" Editors H. Kubinyi, G. Folkers, Y.C. Mertin, Kluwer/ESCOM Dordrecht, TheNetherlands, 1998.
21. Dunn W.J. III, Wold S., Edlund U., Hellberg S., Gasteiger J. Quant. Struct.-Act. Relat. 3:1984;131-137.
22. Cramer R.D. III, Bunce J.D., Patterson D.E., Frank I.E. Quant. Struct.-Act. Relat. 7:1988;18-25.
23. Bush B.L., Nachbar R.B. Jr. J. Comput.-Aided Mol. Design. 7:1993;587-619.
24. Gordaliza M., Castro M.A., Miguel del Corral J.M., López-Vázquez M.L., García P.A., San Feliciano A., García-Grávalos M.D., Broughton H. Tetrahedron. 53:1997;15743.
25. M. Gordaliza, M.A. Castro, J.M. Miguel del Corral, M.L. López-Vázquez, P.A. García, A. San Feliciano, M.D. García-Grávalos, H. Broughton, submitted for publication.
26. M. Gordaliza, M.A. Castro, J.M. Miguel del Corral, P.A. García, A. San Feliciano, unpublished results.